How NOT to Buy AI for Pharmacovigilance: Insights from a Talk by Our CEO, Dmytro Horilyk
At the European Drug Safety & AI Conference 2026, DrugCard CEO Dmytro Horilyk spoke about a challenge many pharmacovigilance teams quietly face when discussing AI